Benchmark Holdings 'momentum is driven by both growth in revenues and disciplined cost control'

Benchmark Holdings PLC’s (LON:BMK) CEO Trond Williksen and CFO Septima Maguire join Proactive London to talk about their results for the year to September which they say will be significantly ahead of market forecasts after all three arms performed ahead of target.

The current consensus is for annual underlying profits (adjusted EBITDA) of £15.9mln, but Benchmark expects to do better than that. Advanced Nutrition has been the stand-out performer, with excellent year-on-year growth, said the AIM-listed business.

Genetics had a strong end to the year while Health saw its first revenues from its sea lice treatment, Ectosan Vet and CleanTreat.